Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vandetanib + FOLFIRI in Colorectal Cancer
NCT00454116Phase 2Completed
- Sponsor
- Sanofi
- Start
- Mar 2007
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 6
01
Overview
Phase 2, randomised, double-blind trial of vandetanib in colorectal cancer (CRC) (3 arms), sponsored by Sanofi. Primary endpoint: Number of Patients With an Objective Disease Progression Event. Started Mar 2007; status: completed.
02
Drugs
vandetanib
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00454116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00454116.